1,968
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Long non-coding RNA NEAT1 can predict various malignant tumour lympha node metastasis: a meta-analysis

, &
Pages 2516-2520 | Received 22 Apr 2019, Accepted 23 May 2019, Published online: 18 Jun 2019

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
  • Knauss JL, Sun T. Regulatory mechanisms of long noncoding RNAs in vertebrate central nervous system development and function. Neuroscience. 2013;235:200–214.
  • Loewen G, Jayawickramarajah J, Zhuo Y, et al. Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014;7:90.
  • Iguchi T, Uchi R, Nambara S, et al. A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer. Anticancer Res. 2015;35:1385–1388.
  • Aken BL, Ayling S, Barrell D, et al. The Ensembl gene annotation system. Database (Oxford). 2016;2016:1–19.
  • Fu JW, Kong Y, Sun X. Long noncoding RNA NEAT1 is an unfavorable prognostic factor and regulates migration and invasion in gastric cancer. J Cancer Res Clin Oncol. 2016;142:1571–1579.
  • Zhao D, Zhang Y, Wang N, et al. NEAT1 negatively regulates miR-218 expression and promotes breast cancer progression. Cbm. 2017;20:247–254.
  • Chen X, Kong J, Ma Z, et al. Up regulation of the long non-coding RNA NEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis. Am J Cancer Res. 2015;5:2808–2815.
  • Li Z, Wei D, Yang C, et al. Overexpression of long noncoding RNA, and NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma. Biomed Pharmacother. 2016;84:244–251.
  • Lu Y, Li T, Wei G, et al. The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma. Tumor Biol. 2016;37:11733–11741.
  • Li YL, Li YH, Chen WP, et al. NEAT expression is associated with tumor recurrence and unfavorable prognosis in colorectal cancer. Oncotarget. 2015;6:27641–27650.
  • Sun C, Li S, Zhang F, et al. Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway. Oncotarget. 2016;7:51784–51814.
  • Li SD, Yang JM, Xia YB, et al. Long noncoding RNA NEAT1 promotes proliferation and invasion via targeting miR-181a-5p in non-small cell lung cancer. Oncol Res. 2018;26:289–296.
  • Huang B, Liu C, Wu Q, et al. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p. Biochem Biophys Res Commun. 2017;482:828–834.
  • Li N, Li ZG, Wei DJ, et al. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma. Cancer Biomark. 2017;19:75–83.
  • Brockdorff N, Ashworth A, Kay GF, et al. The product of the mouse Xist gene is a 15 kb inactive X-specific transcript containing no conserved ORF and located in the nucleus. Cell. 1992;71:515–526.
  • Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21:354–361.
  • Hong HH, Hou LK, Pan X, et al. Long non-coding RNA UCA1 is a predictive biomarker of cancer. Oncotarget. 2016;7:44442–44447.
  • Cui Z, Chen Y, Xiao Z, et al. Long noncoding RNAs as auxiliary biomarkers for gastric cancer screening: a pooled analysis of individual studies. Oncotarget. 2016;7:25791–25800.
  • Gutschner T, Hammerle M, Diederichs S. MALAT1 – a paradigm for long noncoding RNA function in cancer. J Mol Med. 2013;91:791–801.
  • Bond CS, Fox AH. Paraspeckles: nuclear bodies built on long noncoding RNA. J Cell Biol. 2009;186:637–644.
  • Adriaens C, Standaert L, Barra J, et al. p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat Med. 2016;22:861–868.
  • West JA, Mito M, Kurosaka S, et al. Structural, super-resolution microscopy analysis of paraspeckle nuclear body organization. J Cell Biol. 2016;214:817–830.
  • Chen T, Yang H, Wang P, et al. Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis. Onco Targets Ther. 2017;10:993–1000.
  • Zhang YY, Lun LM, Li H, et al. The value of lncRNA NEAT1 as a prognostic factor for survival of cancer outcome: a meta-analysis. Sci Rep. 2017;10:1–9.
  • Oliveiraneto HH, Souza PPC, Da Silva MRB, et al. The expression of chemokines CCL19, CCL21 and their receptor CCR7 in oral squamous cell carcinoma and its relevance to cervical lymph node metastasis. Tumor Biol. 2013;34:65–70.
  • Ramani P, Norton A, Somerville M, et al. PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas. J Neurooncol. 2012;108:375–383.
  • Guo J, Lou W, Ji Y, et al. Effect of CCR7, CXCR4 and VEGF-C on the lymph node metastasis of human pancreatic ductal adenocarcinoma. Oncol Lett. 2013;5:1572–1578.
  • Ganguly KK, Pal S, Moulik S, et al. Integrins and metastasis. Cell Adh Migr. 2013;7:251–261.
  • Huber GF, Fritzsche FR, Züllig L, et al. Podoplanin expression correlates with sentinel lymph node metastasis in early squamous cell carcinomas of the oral cavity and oropharynx. Int J Cancer. 2011;129:1404–1409.